SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Collee MJ)
 

Search: WFRF:(Collee MJ) > Risk-reducing salpi...

  • Mavaddat, N (author)

Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers

  • Article/chapterEnglish2020

Publisher, publication year, extent ...

  • 2020-01-16
  • Springer Science and Business Media LLC,2020

Numbers

  • LIBRIS-ID:oai:prod.swepub.kib.ki.se:143007088
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:143007088URI
  • https://doi.org/10.1186/s13058-020-1247-4DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • BackgroundThe effect of risk-reducing salpingo-oophorectomy (RRSO) on breast cancer risk forBRCA1andBRCA2mutation carriers is uncertain. Retrospective analyses have suggested a protective effect but may be substantially biased. Prospective studies have had limited power, particularly forBRCA2mutation carriers. Further, previous studies have not considered the effect of RRSO in the context of natural menopause.MethodsA multi-centre prospective cohort of 2272BRCA1and 1605BRCA2mutation carriers was followed for a mean of 5.4 and 4.9 years, respectively; 426 women developed incident breast cancer. RRSO was modelled as a time-dependent covariate in Cox regression, and its effect assessed in premenopausal and postmenopausal women.ResultsThere was no association between RRSO and breast cancer forBRCA1(HR = 1.23; 95% CI 0.94–1.61) orBRCA2(HR = 0.88; 95% CI 0.62–1.24) mutation carriers. ForBRCA2mutation carriers, HRs were 0.68 (95% CI 0.40–1.15) and 1.07 (95% CI 0.69–1.64) for RRSO carried out before or after age 45 years, respectively. The HR forBRCA2mutation carriers decreased with increasing time since RRSO (HR = 0.51; 95% CI 0.26–0.99 for 5 years or longer after RRSO). Estimates for premenopausal women were similar.ConclusionWe found no evidence that RRSO reduces breast cancer risk forBRCA1mutation carriers. A potentially beneficial effect forBRCA2mutation carriers was observed, particularly after 5 years following RRSO. These results may inform counselling and management of carriers with respect to RRSO.

Added entries (persons, corporate bodies, meetings, titles ...)

  • Antoniou, AC (author)
  • Mooij, TM (author)
  • Hooning, MJ (author)
  • Heemskerk-Gerritsen, BA (author)
  • Nogues, C (author)
  • Laborde, L (author)
  • Breysse, E (author)
  • Stoppa-Lyonnet, D (author)
  • Gauthier-Villars, M (author)
  • Buecher, B (author)
  • Caron, O (author)
  • Fourme-Mouret, E (author)
  • Fricker, JP (author)
  • Lasset, C (author)
  • Bonadona, V (author)
  • Berthet, P (author)
  • Faivre, L (author)
  • Luporsi, E (author)
  • Mari, V (author)
  • Gladieff, L (author)
  • Gesta, P (author)
  • Sobol, H (author)
  • Eisinger, F (author)
  • Nogues, C (author)
  • Longy, M (author)
  • Dugast, C (author)
  • Colas, C (author)
  • Coupier, I (author)
  • Pujol, P (author)
  • Corsini, C (author)
  • Lortholary, A (author)
  • Vennin, P (author)
  • Adenis, C (author)
  • Nguyen, TD (author)
  • Delnatte, C (author)
  • Tinat, J (author)
  • Tennevet, I (author)
  • Limacher, JM (author)
  • Maugard, C (author)
  • Bignon, YJ (author)
  • Demange, L (author)
  • Penet, C (author)
  • Dreyfus, H (author)
  • Cohen-Haguenauer, O (author)
  • Venat-Bouvet, L (author)
  • Leroux, D (author)
  • Zattara-Cannoni, H (author)
  • Fert-Ferrer, S (author)
  • Bera, O (author)
  • Nogues, C (author)
  • Gauthier-Villars, M (author)
  • Caron, O (author)
  • Gesta, P (author)
  • Pujol, P (author)
  • Lortholary, A (author)
  • Ellis, S (author)
  • Ellis, S (author)
  • Barrowdale, D (author)
  • Frost, D (author)
  • Evans, DG (author)
  • Izatt, L (author)
  • Adlard, J (author)
  • Eeles, R (author)
  • Brewer, C (author)
  • Tischkowitz, M (author)
  • Henderson, A (author)
  • Cook, J (author)
  • Eccles, D (author)
  • Hogervorst, FBL (author)
  • Hogervorst, FBL (author)
  • Collee, JM (author)
  • van Asperen, CJ (author)
  • Mensenkamp, AR (author)
  • Ausems, MGEM (author)
  • Meijers-Heijboer, HEJ (author)
  • van Engelen, K (author)
  • Blok, MJ (author)
  • Oosterwijk, JC (author)
  • Verloop, J (author)
  • van den Broek, E (author)
  • van Engelen, K (author)
  • Mourits, MJE (author)
  • Ausems, MGEM (author)
  • Koppert, LB (author)
  • Hopper, JL (author)
  • John, EM (author)
  • Chung, WK (author)
  • Andrulis, IL (author)
  • Daly, MB (author)
  • Buys, SS (author)
  • Benitez, J (author)
  • Caldes, T (author)
  • Jakubowska, A (author)
  • Simard, J (author)
  • Singer, CF (author)
  • Tan, Y (author)
  • Olah, E (author)
  • Navratilova, M (author)
  • Foretova, L (author)
  • Gerdes, AM (author)
  • Roos-Blom, MJ (author)
  • Van Leeuwen, FE (author)
  • Arver, B (author)
  • Olsson, H (author)
  • Schmutzler, RK (author)
  • Engel, C (author)
  • Kast, K (author)
  • Phillips, KA (author)
  • Terry, MB (author)
  • Milne, RL (author)
  • Goldgar, DE (author)
  • Rookus, MA (author)
  • Andrieu, N (author)
  • Easton, DF (author)

Related titles

  • In:Breast cancer research : BCR: Springer Science and Business Media LLC22:1, s. 8-1465-542X

Internet link

Find in a library

To the university's database

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view